On June 25, 2019, Medtronic notified customers of potential cybersecurity risk in the MiniMed™ 508 and MiniMed™ Paradigm™ series of insulin pumps; these models are from 2012 and earlier. An unauthorized person with special technical skills and equipment could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery. At this time, we have not received any confirmed reports of unauthorized persons changing settings or controlling insulin delivery. Medtronic provided its customers and their doctors with recommended security precautions when using their insulin pump. These include paying attention to any pump notifications, alarms and alerts apart from others. Kindly note that the insulin pumps are not being recalled and are not required to be returned. This is a safety notification only.
In India, Medtronic is proactively informing the regulators and other relevant stakeholders and in the process of working with researchers, doctors and patients to address any questions or concerns that they may have. No patient issues have been reported in India so far. MiniMed™ 508 had been discontinued in India since 2011. Over the years, we’ve launched many advanced models of insulin pumps and they are safe for patients. At Medtronic, we take quality concerns with the utmost seriousness, and the safety of patients is our primary concern. As technologies evolve, we will continue to collaborate with industry researchers and regulators to improve device security approaches and develop high-quality therapies that positively impact lives.